ABSTRACT

Liposomes are gaining traction as a new cancer therapeutic option. A liposome is the first nano-drug delivery system used in clinical trials for next-generation treatments, and it contains the phospholipid bilayer of three vesicles. Its technology is used to reduce drug toxicity, ADR and increase pharmacokinetic action, absorption ratio, drug distribution level. Coordinated theranostic manifestations in cancer treatment using multipronged liposomal drug delivery system has played a key aspect in the growth of cancer drugs such as Doxil, Daunoxome, and Depocyt. For the diagnosis and treatment of many cancers, nanomaterial drug carriers, such as liposomes, are being developed. The varieties of liposomes, composition, preparation, technology and use of cancer medications will be discussed in the upcoming review. Keywords: Liposomes, Drug delivery, vesicles, Nanodrug, Cancer drugs, Technologies
Publication date: 01/01/2023

https://ijbpas.com/pdf/2023/January/MS_IJBPAS_2023_6747.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2023/12.1.6747